Farfel Gail M
EVP/Chief Development Officer at ZOGENIX, INC.; Chief Clinical Dev & Reg Offic at MARINUS PHARMACEUTICALS, INC.
- Sold, on record
- $1.8M
- Dollars the filings state
- Form 4 sales
- 7
- Latest May 12, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ZOGENIX, INC.EVP/Chief Development Officer
- MARINUS PHARMACEUTICALS, INC.Chief Clinical Dev & Reg Offic
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ZOGENIX, INC.32,098 shares
- MARINUS PHARMACEUTICALS, INC.30,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MARINUS PHARMACEUTICALS, INC.UnusualApr 21 2015
Sold 30,000 shares at $9.48 ($284k)
Farfel Gail M, Chief Clinical Dev & Reg Offic
Sold 100% of holdings ($284k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale ZOGENIX, INC.UnusualJun 12 +1148 days
Sold 5,118 shares at $45.00 ($230k)
Farfel Gail M, EVP/Chief Development Officer
Sold 41.7% of holdings ($552k position)7,143 shares leftFirst sale on recordFiling
- 3 Form 4 sale ZOGENIX, INC.UnusualAug 8 +57 days
Sold 7,000 shares at $52.62 ($368k)
Farfel Gail M, EVP/Chief Development Officer
Sold 49.5% of holdings ($744k position)7,143 shares leftFiling
- 4 Form 4 sale ZOGENIX, INC.UnusualSep 4 +27 days
Sold 7,000 shares at $47.58 ($333k)
Farfel Gail M, EVP/Chief Development Officer
Sold 49.5% of holdings ($673k position)7,143 shares leftFiling
- 5 Form 4 sale ZOGENIX, INC.UnusualOct 4 +30 days
Sold 6,961 shares at $43.23 ($301k)
Farfel Gail M, EVP/Chief Development Officer
Sold 49.4% of holdings ($610k position)7,143 shares left1x usual sizeFiling
- 6 Form 4 sale ZOGENIX, INC.UnusualAug 22 +322 days
Sold 3,446 shares at $52.00 ($179k)
Farfel Gail M, EVP/Chief Development Officer
Sold 41.3% of holdings ($434k position)4,891 shares left0.5x usual sizeFiling
- 7 Form 4 sale ZOGENIX, INC.UnusualMay 12 +264 days
Sold 2,573 shares at $28.21 ($73k)
Farfel Gail M, EVP/Chief Development Officer
Sold 33.8% of holdings ($215k position)5,048 shares left0.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 12, 2020 | ZOGENIX, INC. | EVP/Chief Development Officer | Form 4 sale | 2,573 | $73k | 33.8% | Unusual | SEC |
| Aug 22, 2019 | ZOGENIX, INC. | EVP/Chief Development Officer | Form 4 sale | 3,446 | $179k | 41.3% | Unusual | SEC |
| Oct 4, 2018 | ZOGENIX, INC. | EVP/Chief Development Officer | Form 4 sale | 6,961 | $301k | 49.4% | Unusual | SEC |
| Sep 4, 2018 | ZOGENIX, INC. | EVP/Chief Development Officer | Form 4 sale | 7,000 | $333k | 49.5% | Unusual | SEC |
| Aug 8, 2018 | ZOGENIX, INC. | EVP/Chief Development Officer | Form 4 sale | 7,000 | $368k | 49.5% | Unusual | SEC |
| Jun 12, 2018 | ZOGENIX, INC. | EVP/Chief Development Officer | Form 4 sale | 5,118 | $230k | 41.7% | Unusual | SEC |
| Apr 21, 2015 | MARINUS PHARMACEUTICALS, INC. | Chief Clinical Dev & Reg Offic | Form 4 sale | 30,000 | $284k | 100.0% | Unusual | SEC |